Archives of Pharmacy Practice (Jan 2017)
Unusual case of lamivudine-associated skin rashes in an HIV/AIDS patient: a case presentation
Abstract
In patients with human immunodeficiency virus (HIV) infection, lamivudine is used as a first-line drug for antiretroviral therapy. Lamivudine is relatively nontoxic in nature, and it can also be used during pregnancy. Herein, we describe a 43-year-old, HIV-positive female hospitalized with maculopapular, pruritic rash that appeared first on the extremities and gradually spread with systemic symptoms such as fever and myalgia after lamivudine therapy.
Keywords